Atlas Trials

A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea

Clinical trial NCT04589039 · COMPLETED

Trial details

NCT number
NCT04589039
Sponsor
Takeda
Status
COMPLETED
Study type
OBSERVATIONAL
Ovarian Neoplasms
Start date
2020-03-16
Primary completion
2024-09-11
Enrollment
662

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.